Diabetic ketoacidosis risk during the COVID-19 pandemic.
Diabetic ketoacidosis risk during the COVID-19 pandemic.
复制标题
DOI:
10.1016/s2213-8587(21)00241-2
复制
发表时间:
2021-10
期刊:
影响因子:
--
通讯作者:
Umpierrez GE
中科院分区:
文献类型:
--
作者:
Vellanki P;Umpierrez GE
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes. DKA most often occurs in people with type 1 diabetes, but can also occur in patients with poorly controlled type 2 diabetes under stressful conditions. 1 Studies have reported an increased prevalence of DKA in patients with type 1 or type 2 diabetes with COVID-19 infection. Patients admitted to hospital with severe hyperglycaemia and DKA with COVID-19 infection have been shown to have increased severity of complications and a higher rate of mortality compared with patients without COVID-19. 2The Article by Shivani Misra and colleagues3 examined the incidence of emergency hospital admissions coded with DKA in a country-wide database in England. The study focused on three discrete time periods during the COVID-19 pandemic: from March 1 to June 30, 2020 (first wave), July 1 to Oct 31, 2020 (post-first wave), and Nov 1, 2020, to Feb 28, 2021 (second wave), and compared the incidence of DKA admissions during these periods with the mean incidence during the equivalent time periods in the 3 years before the